Incorporating Biological Sex as a Variable in Biomedical Models

50 concepts50 papers

In preclinical research, the pursuit of statistical power often leads to a critical compromise: the exclusion of one biological sex. Historically, male animal models have been treated as the baseline default. The underlying intuition was simple, if flawed: by eliminating the cyclical hormonal fluctuations of female subjects, researchers hoped to minimize experimental noise and isolate clean, reproducible molecular mechanisms.

However, this methodological shortcut creates a profound blind spot. Biological sex is not a superficial variable that can be stripped away to reveal a "universal" physiology. Instead, it is a fundamental organizational axis that shapes every level of biology, from cellular signaling to systemic behavior. When a study relies exclusively on a single sex, it does not eliminate noise; it merely hides a massive source of variance that will inevitably reappear during clinical translation.

The Multi-System Divergence

Why do single-sex models fail so consistently? The answer lies in the pervasive, multi-system divergence driven by biological sex. This dimorphism manifests across several core physiological axes:

Hormonal and Vascular Dynamics

Hormones like estrogen are not merely involved in reproduction; they act as potent systemic regulators. For instance, in vascular health, estrogen exerts significant neuroprotective and vasoactive effects. As noted by Le Yang et al., metabolic models frequently exclude female subjects specifically to avoid the confounding, protective influence of estrogen on cardiovascular and arterial pathways. Yet, this exclusion makes it impossible to understand how environmental stressors affect the broader population.

Robert J. Doonan et al. emphasize that failing to account for these hormonal fluctuations leaves vascular studies unable to accurately map real-world reactivity and tone. Similarly, Huichao Pan et al. point out that in conditions like hypertension, sexual dimorphism fundamentally alters protective molecular pathways, meaning a mechanism mapped in one sex may be entirely absent or altered in the other.

Neuro-Immune and Inflammatory Signaling

The brain's immune landscape is deeply sensitive to biological sex. Microglial activation, neuroinflammation, and pain processing do not operate uniformly across sexes. Yawei Ji et al. demonstrate that preclinical models of chronic pain and depression often fail to generalize because biological sex dictates distinct immune and hormonal responses to neural injury.

When investigating neuroprotective compounds, Chun‐Sheng Yang et al. and Jiajia Bi et al. observe that inflammatory pathologies and microglial polarization manifest in highly sex-specific patterns. Consequently, blocking a specific neuro-immune pathway—such as the spinal cord toll-like receptors studied by Yu Chen et al.—might alleviate pain in a male cohort while proving ineffective in females due to divergent neuro-immune wiring.

Metabolic and Gut-Brain Axes

The complex interplay between diet, the gut microbiota, and neurology is also heavily modulated by sex-specific environments. In a study on insulin sensitivity, Yue Zhong highlights how metabolic interventions interact uniquely with sex-specific hormonal backgrounds, meaning gut-mediated therapies cannot be assumed to act universally.

This sentiment is echoed by Teng Teng et al. and Ye Jiang et al., who argue that isolating the microbiota-gut-brain or microbiota-gut-nerve axis within single-sex cohorts completely ignores how biological sex shapes baseline microbial composition and metabolic processing. Even at the level of maternal programming, De Wu notes that offspring responses to nutritional interventions can exhibit strong sexual dimorphism, rendering single-sex validation incomplete.

The Failure of Unilateral Translation

The ultimate consequence of ignoring these mechanisms is a failure of generalizability. When a therapeutic target or disease pathway is mapped unilaterally, the resulting model lacks predictive power for the excluded sex.

Consider neurodegenerative and psychiatric conditions, which frequently exhibit skewed clinical prevalence rates between men and women. Zhuoqun Wang et al. argue that discovering molecular pathways for Alzheimer's disease exclusively in male models severely limits clinical relevance, given the distinct hormonal variations that govern female neurodegeneration. Conversely, Qingtao Sun et al. demonstrate that relying solely on female subjects to map prefrontal cortex circuits in Alzheimer's models introduces an identical risk: the identified therapeutic targets may lack universality because disease progression is fundamentally sex-linked.

In neuropsychiatric research, the problem is equally acute. Mechanisms of depression, stress resilience, and cognitive flexibility are deeply intertwined with sex-specific biology. Jialin Wu et al. and Juntao Hu et al. emphasize that metabolic and depressive responses to stressors diverge significantly between sexes, meaning a molecular rescue strategy validated in males may fail in females. This is reinforced by Jeremy D. Coplan et al. and Wen Chen et al., who show that neurodevelopmental and stress-induced pathologies reshape neural structures like the amygdala and prefrontal cortex through distinct, sex-dependent mechanisms.

Designing for Generalizability

Building true intuition for why sex-inclusive design works requires shifting our perspective on experimental variance. Including both male and female cohorts is not an administrative burden or a threat to statistical power; it is a prerequisite for discovering robust, reproducible biological truths.

When researchers like Yun-An Lim et al. or Sharmelee Selvaraji et al. advocate for dual-sex validation in vascular dementia models, they are acknowledging that a true therapeutic target must withstand the physiological realities of both hormonal environments. By treating biological sex as a core independent variable rather than a confounding nuisance, biomedical science can move away from fragile, single-sex insights and toward therapies that genuinely generalize to the entire human population.

History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_biological_sex_bias_b4d8e740,
  title = {biological sex bias},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/biological-sex-bias/rdr_b4d8e74029ec4b07a2552d81e45fe10f},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_biological_sex_bias_b4d8e740_v1,
  title = {biological sex bias},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/biological-sex-bias/rdr_b4d8e74029ec4b07a2552d81e45fe10f/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}

See something wrong? Report a mistake